Inhibition of androgen receptor promotes CXC-chemokine receptor 7-mediated prostate cancer cell survival
Abstract The atypical C-X-C chemokine receptor 7 (CXCR7) has been implicated in supporting aggressive cancer phenotypes in several cancers including prostate cancer. However, the mechanisms driving overexpression of this receptor in cancer are poorly understood. This study investigates the role of a...
Main Authors: | James J. Hoy, Georgios Kallifatidis, Diandra K. Smith, Bal L. Lokeshwar |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-02918-3 |
Similar Items
-
CXC Chemokine/Receptor Axis Profile and Metastasis in Prostate Cancer
by: Naoya Nagaya, et al.
Published: (2020-10-01) -
The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
by: Jan Korbecki, et al.
Published: (2021-01-01) -
Study of the Structure and Function of CXC Chemokine Receptor 2
by: Kwon, Hae Ryong
Published: (2010) -
Design and characterization of an ELR-CXC chemokine receptor antagonist
by: LIN, Li-Jin, et al.
Published: (2015) -
Interleukin-17 induces CC chemokine receptor 6 and CXC chemokine receptor 7 expression in human colorectal carcinoma cells
by: Ting-Ying SUNG, et al.